Cargando…

Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis

Bleeding from oesophageal varices, oesophageal ulcers or oesophagitis is occasionally massive and difficult to control. Octreotide, a synthetic analogue of somatostin lowers portal pressure and collateral blood flow including that through varices, increases lower oesophageal sphincter pressure, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Spencer A., Kingsnorth, Andrew N., Ellenbogen, Simon, Copeland, Graham, Davies, Nicholas, Sutton, Robert, Shields, Robert
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423826/
https://www.ncbi.nlm.nih.gov/pubmed/9187545
http://dx.doi.org/10.1155/1996/39486
_version_ 1782156189606346752
author Jenkins, Spencer A.
Kingsnorth, Andrew N.
Ellenbogen, Simon
Copeland, Graham
Davies, Nicholas
Sutton, Robert
Shields, Robert
author_facet Jenkins, Spencer A.
Kingsnorth, Andrew N.
Ellenbogen, Simon
Copeland, Graham
Davies, Nicholas
Sutton, Robert
Shields, Robert
author_sort Jenkins, Spencer A.
collection PubMed
description Bleeding from oesophageal varices, oesophageal ulcers or oesophagitis is occasionally massive and difficult to control. Octreotide, a synthetic analogue of somatostin lowers portal pressure and collateral blood flow including that through varices, increases lower oesophageal sphincter pressure, and inhibits the gastric secretion of acid as well as pepsin. Our current experience suggests it is effective in controlling acute variceal haemorrhage. Therefore we have examined the efficacy of octreotide in the control of postsclerotherapy bleeding from oesophageal varices, oesophageal ulcers and oesophagitis. During the study period 77 patients experienced a significant gastrointestinal bleed (blood pressure < 100 mm Hg, pulse > 100 beats per min or the need to transfuse 2 or more units of blood to restore the haemoglobin level) following injection sclerotherapy of oesophageal varices. The source of bleeding was varices in 42 patients, oesophageal ulcers in 31 and oesophagitis in 4. All patients received a continuous intravenous infusion of octreotide (50 μg/h) for between 40–140h. If bleeding was not controlled in the first 12h after commencing octreotide hourly bolus doses (50 μg) for 24h were superimposed on the continuous infusion. Haemorrhage was successfully controlled by an infusion of octreotide in 38 of the 42 patients with bleeding from varices, in 30 of 31 patients with oesophageal ulceration, and all patients with oesophagitis. In the 1 patient with persistent bleeding from oesophageal ulceration and in 2 of the 4 with continued haemorrhage from varices, haemostasis was achieved by hourly boluses of 50 μg octreotide for 24h in addition to the continuous infusion. No major complications were associated with octreotide administration. The results of this study clearly indicate that octreotide is a safe and effective treatment for the control of severe haemorrhage after technically successful injection sclerotherapy.
format Text
id pubmed-2423826
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-24238262008-07-08 Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis Jenkins, Spencer A. Kingsnorth, Andrew N. Ellenbogen, Simon Copeland, Graham Davies, Nicholas Sutton, Robert Shields, Robert HPB Surg Research Article Bleeding from oesophageal varices, oesophageal ulcers or oesophagitis is occasionally massive and difficult to control. Octreotide, a synthetic analogue of somatostin lowers portal pressure and collateral blood flow including that through varices, increases lower oesophageal sphincter pressure, and inhibits the gastric secretion of acid as well as pepsin. Our current experience suggests it is effective in controlling acute variceal haemorrhage. Therefore we have examined the efficacy of octreotide in the control of postsclerotherapy bleeding from oesophageal varices, oesophageal ulcers and oesophagitis. During the study period 77 patients experienced a significant gastrointestinal bleed (blood pressure < 100 mm Hg, pulse > 100 beats per min or the need to transfuse 2 or more units of blood to restore the haemoglobin level) following injection sclerotherapy of oesophageal varices. The source of bleeding was varices in 42 patients, oesophageal ulcers in 31 and oesophagitis in 4. All patients received a continuous intravenous infusion of octreotide (50 μg/h) for between 40–140h. If bleeding was not controlled in the first 12h after commencing octreotide hourly bolus doses (50 μg) for 24h were superimposed on the continuous infusion. Haemorrhage was successfully controlled by an infusion of octreotide in 38 of the 42 patients with bleeding from varices, in 30 of 31 patients with oesophageal ulceration, and all patients with oesophagitis. In the 1 patient with persistent bleeding from oesophageal ulceration and in 2 of the 4 with continued haemorrhage from varices, haemostasis was achieved by hourly boluses of 50 μg octreotide for 24h in addition to the continuous infusion. No major complications were associated with octreotide administration. The results of this study clearly indicate that octreotide is a safe and effective treatment for the control of severe haemorrhage after technically successful injection sclerotherapy. Hindawi Publishing Corporation 1996 /pmc/articles/PMC2423826/ /pubmed/9187545 http://dx.doi.org/10.1155/1996/39486 Text en Copyright © 1996 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jenkins, Spencer A.
Kingsnorth, Andrew N.
Ellenbogen, Simon
Copeland, Graham
Davies, Nicholas
Sutton, Robert
Shields, Robert
Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis
title Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis
title_full Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis
title_fullStr Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis
title_full_unstemmed Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis
title_short Octreotide in the Control of Post-Sclerotherapy Bleeding from Oesophageal Varices, Ulcers and Oesophagitis
title_sort octreotide in the control of post-sclerotherapy bleeding from oesophageal varices, ulcers and oesophagitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423826/
https://www.ncbi.nlm.nih.gov/pubmed/9187545
http://dx.doi.org/10.1155/1996/39486
work_keys_str_mv AT jenkinsspencera octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis
AT kingsnorthandrewn octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis
AT ellenbogensimon octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis
AT copelandgraham octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis
AT daviesnicholas octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis
AT suttonrobert octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis
AT shieldsrobert octreotideinthecontrolofpostsclerotherapybleedingfromoesophagealvaricesulcersandoesophagitis